These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8610774)

  • 1. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status.
    Gilabert J; Estellés A; Cano A; España F; Barrachina R; Grancha S; Aznar J; Tortajada M
    Am J Obstet Gynecol; 1995 Dec; 173(6):1849-54. PubMed ID: 8610774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
    Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
    Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy.
    Nozaki M; Ogata R; Koera K; Hashimoto K; Nakano H
    Climacteric; 1999 Jun; 2(2):124-30. PubMed ID: 11910665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
    Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
    Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
    Andersen LF; Gram J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):283-9. PubMed ID: 9988788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors.
    Chen FP; Lee N; Soong YK; Huang KE
    Menopause; 2001; 8(5):347-52. PubMed ID: 11528361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of endogenous anticoagulants (antithrombin III, protein C and protein S) in women after menopause treated with hormone replacement therapy (transdermal 17 beta-OH estradiol and oral medroxyprogesterone acetate)].
    Ciepłuch R; Czestochowska E
    Ginekol Pol; 1996 Aug; 67(8):407-10. PubMed ID: 9139010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J
    Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of hormone replacement therapy containing transdermal 17-beta estradiol and oral medroxyprogesterone acetate on coagulation and fibrinolysis].
    Stachowiak G; Owczarek D; Połać I; Pertyński T; Jedrzejczyk S
    Ginekol Pol; 1999 Aug; 70(8):527-33. PubMed ID: 10534929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.
    Djurovic S; Os I; Hofstad AE; Abdelnoor M; Westheim A; Berg K
    J Intern Med; 2000 Feb; 247(2):279-85. PubMed ID: 10692092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.
    Zegura B; Keber I; Sebestjen M; Koenig W
    Atherosclerosis; 2003 May; 168(1):123-9. PubMed ID: 12732395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
    Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transdermal oestradiol and oral progestogens on haemostasis variables.
    Kroon UB; Tengborn L; Rita H; Bäckström AC
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():32-7. PubMed ID: 9389781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of two regimens of hormone replacement therapy on the haemostatic profile in postmenopausal women.
    van Wersch JW; Ubachs JM; van den Ende A; van Enk A
    Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):449-53. PubMed ID: 7918843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study.
    Hoibraaten E; Os I; Seljeflot I; Andersen TO; Hofstad A; Sandset PM
    Thromb Res; 2000 Apr; 98(1):19-27. PubMed ID: 10706930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.